Lo Monaco, Maria Rita
 Distribuzione geografica
Continente #
NA - Nord America 4.164
AS - Asia 3.550
EU - Europa 2.764
SA - Sud America 651
AF - Africa 143
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.287
Nazione #
US - Stati Uniti d'America 4.016
SG - Singapore 1.600
CN - Cina 702
IT - Italia 684
BR - Brasile 543
SE - Svezia 448
DE - Germania 414
VN - Vietnam 394
FR - Francia 312
HK - Hong Kong 206
IE - Irlanda 170
GB - Regno Unito 169
IN - India 110
ID - Indonesia 108
FI - Finlandia 95
JP - Giappone 90
CA - Canada 82
RU - Federazione Russa 78
PL - Polonia 70
UA - Ucraina 57
BE - Belgio 55
NL - Olanda 52
CI - Costa d'Avorio 51
KR - Corea 49
TR - Turchia 47
MX - Messico 46
IQ - Iraq 44
AT - Austria 41
BD - Bangladesh 38
AR - Argentina 36
ZA - Sudafrica 32
ES - Italia 30
SA - Arabia Saudita 23
IR - Iran 22
EC - Ecuador 20
UZ - Uzbekistan 15
CH - Svizzera 14
CZ - Repubblica Ceca 14
JO - Giordania 14
VE - Venezuela 14
PK - Pakistan 13
PH - Filippine 12
CO - Colombia 10
IL - Israele 10
KE - Kenya 10
EG - Egitto 9
GR - Grecia 9
AU - Australia 8
BO - Bolivia 8
LT - Lituania 8
MA - Marocco 8
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
RO - Romania 6
CL - Cile 5
ET - Etiopia 5
MY - Malesia 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
KW - Kuwait 4
LU - Lussemburgo 4
NI - Nicaragua 4
PE - Perù 4
PY - Paraguay 4
RS - Serbia 4
TW - Taiwan 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CG - Congo 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
SN - Senegal 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
MK - Macedonia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BF - Burkina Faso 1
BW - Botswana 1
Totale 11.265
Città #
Singapore 906
San Jose 496
Ashburn 487
Chandler 437
Dublin 168
New York 160
Rome 159
Ho Chi Minh City 139
Beijing 136
Milan 126
Los Angeles 120
Ann Arbor 119
The Dalles 111
Hefei 108
Hanoi 104
Jakarta 97
Lauterbourg 88
Tokyo 84
Hong Kong 82
Dallas 81
Chicago 79
Frankfurt am Main 72
Munich 62
São Paulo 60
Warsaw 60
Abidjan 51
Helsinki 50
Boardman 48
Cattolica 47
Moscow 46
Boston 45
Brussels 44
Princeton 43
San Mateo 43
Wilmington 42
Council Bluffs 40
Marseille 40
Houston 38
North Bergen 35
Seoul 35
Kent 34
St Louis 31
Nanjing 29
Jacksonville 28
London 28
Nuremberg 28
Ottawa 27
Santa Clara 27
Amsterdam 26
Dearborn 26
Woodbridge 24
Fairfield 23
Orem 23
Paris 23
Washington 23
Izmir 21
Redwood City 21
Turku 21
Vienna 21
Denver 20
Johannesburg 20
Bremen 19
Da Nang 19
Rio de Janeiro 19
Haiphong 18
Atlanta 17
Baghdad 17
Brooklyn 17
Lappeenranta 17
Trieste 17
Buffalo 16
Cambridge 16
Chennai 16
Seattle 16
Mexico City 15
Montreal 15
Pune 15
Düsseldorf 14
Phoenix 14
Stockholm 14
Belo Horizonte 13
Guangzhou 13
Lancaster 13
Manchester 13
Poplar 13
Amman 12
Leawood 12
Nürnberg 12
Tashkent 12
Brno 11
City of London 11
Kish 11
Naples 11
Norwalk 11
Redmond 11
Tianjin 11
Toronto 11
Augusta 10
Falkenstein 10
Portsmouth 10
Totale 6.254
Nome #
Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. 250
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease Select item 29019160 1. The role of cognitive reserve in cognitive aging: what we can learn from Parkinson's disease. 215
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 214
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 201
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 197
Assessment of neurological manifestations in hospitalized patients with COVID-19 195
Residual respiratory impairment after COVID-19 pneumonia 190
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 172
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 170
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 170
Residual respiratory impairment after COVID-19 pneumonia 169
Laterality in Parkinson's disease may predict motor and visual imagery abilities 162
The impact of cognitive reserve on the effectiveness of balance rehabilitation in Parkinson's disease 155
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 155
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 150
Use of ACE-inhibitors and falls in patients with Parkinson's disease 148
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 147
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 143
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 142
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 142
Association of metabolic syndrome with falls in patients with Parkinson's disease 140
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 138
Comparison of virtual reality rehabilitation and conventionalrehabilitation in Parkinson’s disease: a randomised controlledtrial 137
What about the caregiver? A journey into Parkinson’s disease following the burden tracks 136
Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation 134
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 134
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 131
Gender may be related to the side of the motorsyndrome and cognition in idiopathic Parkinson’sdisease 126
Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors 125
F057 Affective and cognitive components of theory of mind in Huntington’s disease: yoni task performance in early and mid-disease stages 124
Safinamide as an adjunct therapy in older patients with Parkinson’s disease: a retrospective study 124
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 122
Use of proton-pump inhibitors is associated with depression: a population-based study 120
Writing errors in primary progressive aphasia 118
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Theory of mind: A clue for the interpretation of functional movement disorders 116
Polypharmacy is a determinant of hospitalization in Parkinson's disease 116
Untangling the relationship between fat distribution, nutritional status and Parkinson's disease severity 114
Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity 114
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 112
Word selection processing in Parkinson's disease: When nouns are more difficult than verbs 112
Circulating amino acid signature in older people with Parkinson's disease: A metabolic complement to the EXosomes in PArkiNson Disease (EXPAND) study 112
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 111
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 111
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 110
Mitochondrial dysfunction and aging: Insights from the analysis of extracellular vesicles 108
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 107
What about the caregiver? A journey into Parkinson's disease following the burden tracks 106
Should face masks be worn to contain the spread of COVID-19 in the postlockdown phase? 106
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 105
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases 104
Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial 103
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 101
Association of Pisa Syndrome With Mortality in Patients With Parkinson's Disease 101
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort 101
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 101
Social cognition in Parkinson's disease and functional movement disorders 100
Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19 99
Assessment of neurological manifestations in hospitalized patients with COVID-19 98
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 98
Gender may be related to the side of the motor syndrome and cognition in idiopathic Parkinson's disease 97
The Geriatrician: The Frontline Specialist in the Treatment of COVID-19 Patients 92
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-COV-2 Pandemic Infection 92
An educational case series of Parkinson's disease during the COVID-19 pandemic 91
Association between frailty and ischemic heart disease: a systematic review and meta-analysis 89
Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey 88
Safinamide as an adjunct therapy in older patients with Parkinson's disease: a retrospective study 87
Writing errors in primary progressive aphasia 87
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 87
Impaired processing of conspecifics in Parkinson's disease 86
Efficacy and safety of long-term botulinum toxin treatment for acquired cervical dystonia: a 25-year follow-up 86
Balancing the risks and benefits of antipsychotic medications for symptom management in older patients with cancer 86
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 86
An educational case series of Parkinson's disease during the COVID-19 pandemic 85
Fucntional and clinical correlates of carotid intimal thickness in obstructive sleep apnea syndrome 85
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 78
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington’s and Parkinson’s diseases 78
Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end? 77
Encephalopathy as neurological involvement of SARS-COV-2 infection 74
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease 72
Correction to: Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington’s disease (Journal of Neurology, (2022), 269, 12, (6634-6640), 10.1007/s00415-022-11297-3) 72
Clinical and MRI characterization of apraxic syndrome in corticobasal degeneration: A single-case study 70
Theory of mind: A clue for the interpretation of functional movement disorders 70
The effects of cognitive impairment on mortality among hospitalized patients with heart failure 70
Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure 69
Of microbes and minds: A narrative review on the second brain aging 63
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 63
An early feasibility study for neurological devices: The ARCTRAN study 60
The “development of metabolic and functional markers of dementia in older people” (ODINO) study: Rationale, design and methods 57
Subacute onset dystonia in a woman affected by Parkinson's disease following SARS-COV-2 infection 56
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 52
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 46
An early feasibility study for neurological devices: The ARCTRAN study 42
Neuropsychological measures of post-COVID-19 cognitive status 42
Coronary risk factors in the elderly: Their interactions and treatment 40
Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study 35
Totale 11.492
Categoria #
all - tutte 52.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 47 20
2021/2022540 38 21 13 44 31 18 15 81 15 43 107 114
2022/20231.586 160 167 85 215 73 165 108 103 332 87 76 15
2023/20241.182 37 245 74 83 75 198 76 63 16 73 101 141
2024/20252.180 50 51 168 90 169 101 90 76 302 218 483 382
2025/20265.007 727 203 384 613 828 267 954 295 310 413 13 0
Totale 11.492